PNVL3DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOSCompany Data · 2T26updated 2026-08-24
1
Overview
4T10 — 2T26 · 63 quarters
▼
DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.
SectorComércio (Atacado e Varejo)
Company HeadquartersEldorado do Sul, RS
Full Time Employees—
CEOMr. Julio Ricardo Mottin Neto
Listing SegmentNovo Mercado
Foundation1920
Customer Rating—
Employee Rating—
Estrutura Acionária
73%Free Float
Julio Ricardo Andrighetto Mottin9%
Spx Gestão De Recursos Ltda6%
Roberto Luiz Weber4%
Geraldo Otto Weber4%
Denis Pizzato4%
Free Float73%
Valuation
| Price | R$ 11,51 |
| Shares Outstanding | 149.376 |
| Market Capitalization | 1.719 |
| ( - ) Cash & Equivalents | 295 |
| ( + ) Total Debt | 1.404 |
| ( = ) Enterprise Value | 2.828 |
| P/E | 12,5x |
| EV / EBITDA | 5,4x |
R$ 11,51
Adj close · daily
Income Statement
| Revenue | 5.898 |
| EBITDA | 523 |
| EBIT | 281 |
| Net Income | 138 |
| SG&A % | (27,8%) |
Balance Sheet
| Assets | 3.710 |
| Cash | 295 |
| Total Debt | 1.404 |
| Net Debt | 1.109 |
| Fixed Assets | 1.442 |
| Working Capital | 1.066 |
| Equity | 1.317 |
Invested Capital & Reinvestment
| Invested Capital Turnover | 1,92x |
| Marginal IC Turnover | 3,23x |
| Reinvestment % NOPAT | (15,2%) |
| Working Capital Turnover | 5,69x |
| Cash Conv. Cycle | 85,2 |
| Fixed Assets Turnover | 4,16x |
| D&A % Fixed Assets | 17,5% |
| Capex % Revenue | 2,6% |
7,7 %
RoIC · LTM
RoIC (LTM)
Margins & Returns
| Revenue Growth | 14,4% |
| Gross Margin | 32,3% |
| EBITDA Margin | 8,9% |
| Net Income Margin | 2,3% |
| Effective Tax Rate | 14,6% |
| Operating Leverage | 1,52x |
| RoIC | 7,7% |
| RoE | 10,7% |
Capital Structure
| Current Ratio | 1,75x |
| Financial Leverage | 2,82x |
| Asset Turnover | 1,60x |
| Net Debt / EBITDA | 2,12x |
| Net Debt & Lease / EBITDA | 3,63x |
Cash Flow
| CFO Conversion | 80,5% |
| FCFF Yield | 8,7% |
| FCFE Yield | 18,3% |
| Payout Ratio | 21,1% |
| Dividend Yield | 1,5% |
| Interest % FCFF | 0,0% |
Latest CVM filings
- 2026-08-08reported 2T26
- 2026-05-06reported 1T26
- 2026-03-19reported 4T25
- 2025-11-06reported 3T25
- 2025-08-14reported 2T25
- 2025-05-14reported 1T25